Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock $0.001 par value per share
-
Shares outstanding
-
77,821,012
-
Total 13F shares
-
15,014,401
-
Share change
-
+15,014,401
-
Total reported value
-
$80,763,090
-
Price per share
-
$5.38
-
Number of holders
-
30
-
Value change
-
+$80,763,090
-
Number of buys
-
30
Institutional Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q4 2022
As of 31 Dec 2022,
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,014,401 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, Camber Capital Management LP, Laurion Capital Management LP, Artal Group S.A., Alyeska Investment Group, L.P., K2 PRINCIPAL FUND, L.P., VANGUARD GROUP INC, and Finepoint Capital LP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.